117 related articles for article (PubMed ID: 8978457)
1. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth.
Hatzoglou A; Bakogeorgou E; Papakonstanti E; Stournaras C; Emmanouel DS; Castanas E
J Cell Biochem; 1996 Dec; 63(4):410-21. PubMed ID: 8978457
[TBL] [Abstract][Full Text] [Related]
2. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
Townsend D; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
[TBL] [Abstract][Full Text] [Related]
3. Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth.
Hatzoglou A; Ouafik L; Bakogeorgou E; Thermos K; Castanas E
Cancer Res; 1995 Dec; 55(23):5632-6. PubMed ID: 7585646
[TBL] [Abstract][Full Text] [Related]
4. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
[TBL] [Abstract][Full Text] [Related]
5. Kappa opioids exert a strong antiproliferative effect on PC12 rat pheochromocytoma cells.
Venihaki M; Gravanis A; Margioris AN
Peptides; 1996; 17(3):413-9. PubMed ID: 8735967
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
Standifer KM; Cheng J; Brooks AI; Honrado CP; Su W; Visconti LM; Biedler JL; Pasternak GW
J Pharmacol Exp Ther; 1994 Sep; 270(3):1246-55. PubMed ID: 7932177
[TBL] [Abstract][Full Text] [Related]
7. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
Hatzoglou A; Bakogeorgou E; Castanas E
Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
[TBL] [Abstract][Full Text] [Related]
8. Opioid-somatostatin interactions in regulating cancer cell growth.
Hatzoglou A; Kampa M; Castanas E
Front Biosci; 2005 Jan; 10():244-56. PubMed ID: 15574365
[TBL] [Abstract][Full Text] [Related]
9. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
[TBL] [Abstract][Full Text] [Related]
10. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
Watson B; Meng F; Akil H
Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems.
Panagiotou S; Hatzoglou A; Calvo F; Martin PM; Castanas E
J Cell Biochem; 1998 Dec; 71(3):416-28. PubMed ID: 9831078
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions.
Shang Y; LeRouzic V; Schneider S; Bisignano P; Pasternak GW; Filizola M
Biochemistry; 2014 Aug; 53(31):5140-9. PubMed ID: 25073009
[TBL] [Abstract][Full Text] [Related]
15. Early alterations of actin cytoskeleton in OK cells by opioids.
Papakonstanti EA; Bakogeorgou E; Castanas E; Emmanouel DS; Hartig R; Stournaras C
J Cell Biochem; 1998 Jul; 70(1):60-9. PubMed ID: 9632108
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.
Livingston KE; Stanczyk MA; Burford NT; Alt A; Canals M; Traynor JR
Mol Pharmacol; 2018 Feb; 93(2):157-167. PubMed ID: 29233847
[TBL] [Abstract][Full Text] [Related]
17. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal mu-, delta- and kappa-opioid receptors.
Rattan AK; Tejwani GA
Pharmacology; 1994 Jan; 48(1):30-40. PubMed ID: 8309985
[TBL] [Abstract][Full Text] [Related]
18. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line.
Hatzoglou A; Bakogeorgou E; Hatzoglou C; Martin PM; Castanas E
Eur J Pharmacol; 1996 Aug; 310(2-3):217-23. PubMed ID: 8884220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
